Biocon Pharma gets GMP compliance certificate from UK's health regulator MHRA for Bengaluru facility
The certificate, which includes manufacturing and packaging of tablets and capsules in the non-potent and potent blocks of the facility, was issued based on a remote inspection
Biocon executive chairperson Kiran Mazumdar Shaw tests COVID-19 positive, says her symptoms are mild
'I have added to the COVID-18 count by testing positive. Mild symptoms and I hope it stays that way,' the 67-year-old biotechnology industry veteran said in a tweet
Drugs Controller General of India approved monoclonal antibody injection Itolizumab for limited use to treat moderate to severe cases of COVID-19.
Biotechnology major Biocon has reported a 42 percent decline in its consolidated net profit to Rs 123 crore for the quarter ended March 2020, mainly on account of the one-time coronavirus-related impact on its biologics business
Biocon Ltd announced on Monday that The Medicine Maker Power List 2020 has ranked its Executive Chairperson Kiran Mazumdar-Shaw as one of the world's top 20 inspirational leaders in the field of biopharmaceuticals
Biocon Biologics India Ltd., a subsidiary of Biocon Ltd., said on Thursday it has received the Establishment Inspection Report (EIR) from the USFDA (the United States Food and Drug Administration) for the pre-approval inspection at two of its biologics manufacturing facilities in Bengaluru
Biocon will continue to operate essential pharmaceutical manufacturing in full compliance with government requirements, it added.
Citizenship Amendment Act: Microsoft chief Satya Nadella's views are modern and progressive, and subtly question new law
A day after Microsoft CEO Satya Nadella termed situation surrounding the Citizenship Amendment Act as "sad", his company on Tuesday issued a far subtler statement on the contentious Act, that conveyed his optimism for an immigrant in India who could benefit the society and economy
Biocon appoints MB Chinappa as CFO of Biocon Biologics; to be part of company's executive leadership team
Chinappa joins Biocon Biologics from Biocon's subsidiary company Syngene International Ltd, where he was President (Finance) and CFO since 2008, the company said in a filing to the BSE.
Karvy case gets murkier, who benefited the most from India's economic growth; all this and more on Moneycontrol Pro
The Karvy case is becoming messier by the day and threatens to take down an important segment of the market—loans against shares (LAS)— albeit for the short term.
Biotechnology major Biocon and drug firm Mylan NV on Monday announced the launch of biosimilar Ogivri, used for treatment of certain breast and gastric cancers, in the US market.
Nirmala Sitharaman wrong in playing down Rahul Bajaj criticism: How does questioning govt hurt national interest?
Soon after Bajaj’s comment, Biocon chief Kiran Mazumdar Shaw tweeted her views on the same lines.
Kiran Mazumdar Shaw settles alleged insider trading case with SEBI in Infosys matter, pays Rs 3 lakh charges
SEBI had conducted an examination in the matter of Infosys and observed that Mazumdar Shaw had delayed making the requisite disclosures with respect to change in her shareholding in the company.
'Centre is concerned about tax terrorism, but what has been done to stop it': Mohandas Pai on 'threatening' calls to Kiran Mazumdar-Shaw
The phone call from the 'government official' to Mazumdar-Shaw is reflective of the attitude of government officials, Pai said
CCD founder VG Siddhartha's death fuels Corporate India's anger over govt's 'overzealous' crackdown on fraud, tax evasion
Tax collectors are also under pressure, government sources familiar with the matter have said, declining to be identified as they were not authorized to speak on the matter.
Biocon chairperson Kiran Mazumdar Shaw has lamented that she is struggling to find enough women to play leadership roles, even though there is a significant rise in their number in junior management roles
India is under-invested in science and technology and treading a very scary path: Shaw.
Biocon Q2 net profit jumps five-fold to Rs 355 cr on exceptional gain; income rises 35% to Rs 1,375 cr
Biocon's exceptional gain was on account of change in fair value of its investment in Equillium Inc.
Godrej's Smita Crishna, HCL's Roshni Nadar, Kiran Mazumdar Shaw lead list of India's top 10 wealthiest women
Crishna, a third generation heir of Godrej empire, leads the list with an estimated wealth of Rs 37,570 crore.
Unlike other economies, the Indian government is the primary source of science research funding as well as the primary user of those funds, Shaw noted.